Monogenic causes of stroke: now and the future
- PMID: 26037017
- DOI: 10.1007/s00415-015-7794-4
Monogenic causes of stroke: now and the future
Abstract
Most stroke is multifactorial with multiple polygenic risk factors each conferring small increases in risk interacting with environmental risk factors, but it can also arise from mutations in a single gene. This review covers single-gene disorders which lead to stroke as a major phenotype, with a focus on those which cause cerebral small vessel disease (SVD), an area where there has been significant recent progress with findings that may inform us about the pathogenesis of SVD more broadly. We also discuss the impact that next generation sequencing technology (NGST) is likely to have on clinical practice in this area. The most common form of monogenic SVD is cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, due to the mutations in the NOTCH3 gene. Several other inherited forms of SVD include cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy, retinal vasculopathy with cerebral leukodystrophy, collagen type IV α1 and α2 gene-related arteriopathy and FOXC1 deletion related arteriopathy. These monogenic forms of SVD, with overlapping clinical phenotypes, are beginning to provide insights into how the small arteries in the brain can be damaged and some of the mechanisms identified may also be relevant to more common sporadic SVD. Despite the discovery of these disorders, it is often challenging to clinically and radiologically distinguish between syndromes, while screening multiple genes for causative mutations that can be costly and time-consuming. The rapidly falling cost of NGST may allow quicker diagnosis of these rare causes of SVD, and can also identify previously unknown disease-causing variants.
Keywords: CADASIL; CARASIL; COL4A1; Genetics; Next generation sequencing; Retinal vasculopathy with cerebral leukodystrophy; Small vessel disease; Stroke.
Similar articles
-
New insights into mechanisms of small vessel disease stroke from genetics.Clin Sci (Lond). 2017 Apr 1;131(7):515-531. doi: 10.1042/CS20160825. Clin Sci (Lond). 2017. PMID: 28302914 Review.
-
Hereditary cerebral small vessel diseases: a review.J Neurol Sci. 2012 Nov 15;322(1-2):25-30. doi: 10.1016/j.jns.2012.07.041. Epub 2012 Aug 4. J Neurol Sci. 2012. PMID: 22868088 Review.
-
Monogenic Causes of Strokes.Genes (Basel). 2021 Nov 23;12(12):1855. doi: 10.3390/genes12121855. Genes (Basel). 2021. PMID: 34946804 Free PMC article. Review.
-
Hereditary cerebral small vessel disease and stroke.Clin Neurol Neurosurg. 2017 Apr;155:45-57. doi: 10.1016/j.clineuro.2017.02.015. Epub 2017 Feb 22. Clin Neurol Neurosurg. 2017. PMID: 28254515 Review.
-
Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome.Int J Mol Sci. 2019 Sep 3;20(17):4298. doi: 10.3390/ijms20174298. Int J Mol Sci. 2019. PMID: 31484286 Free PMC article. Review.
Cited by
-
Genetic Insights into Cerebrovascular Disorders: A Comprehensive Review.J Vasc Interv Neurol. 2017 Oct;9(5):21-32. J Vasc Interv Neurol. 2017. PMID: 29163746 Free PMC article. No abstract available.
-
Nucleic Acid Therapies for Ischemic Stroke.Neurotherapeutics. 2019 Apr;16(2):299-313. doi: 10.1007/s13311-019-00710-x. Neurotherapeutics. 2019. PMID: 30635869 Free PMC article. Review.
-
Genetic variation at 16q24.2 is associated with small vessel stroke.Ann Neurol. 2017 Mar;81(3):383-394. doi: 10.1002/ana.24840. Ann Neurol. 2017. PMID: 27997041 Free PMC article.
-
Migraine and stroke.Stroke Vasc Neurol. 2017 May 29;2(3):160-167. doi: 10.1136/svn-2017-000077. eCollection 2017 Sep. Stroke Vasc Neurol. 2017. PMID: 28989805 Free PMC article. Review.
-
Loss of the serine protease HTRA1 impairs smooth muscle cells maturation.Sci Rep. 2019 Dec 3;9(1):18224. doi: 10.1038/s41598-019-54807-6. Sci Rep. 2019. PMID: 31796853 Free PMC article.
References
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous